XML 73 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Financing Arrangements - Narrative (Details)
1 Months Ended 3 Months Ended
May 12, 2020
USD ($)
Jul. 31, 2019
USD ($)
Jun. 30, 2019
USD ($)
Jul. 31, 2020
USD ($)
Jul. 26, 2019
USD ($)
May 12, 2020
JPY (¥)
Apr. 24, 2020
USD ($)
Jun. 30, 2019
EUR (€)
tranche
Senior Notes                
Principal value       $ 25,500,000,000     $ 24,500,000,000  
Cash proceeds, net of discounts and issuance costs       0 $ 5,567,000,000      
Loss on extinguishment of debt       0 406,000,000      
Financial Instruments Not Measured at Fair Value                
Long-term debt, including the current portion, fair value       28,900,000,000     27,100,000,000  
Term Loan Agreements | Medtronic Luxco                
Line of Credit Facility                
Term of debt instrument 6 months              
Senior Notes                
Principal value $ 2,800,000,000         ¥ 300,000,000,000    
Term Loan Agreements                
Additional extension option, term of extension 6 months              
Term Loan Agreements | Medtronic Luxco | TIBOR Rate                
Term Loan Agreements                
Margin added to variable rate 0.50%              
Commercial Paper Program | Commercial Paper                
Commercial Paper                
Commercial paper, maximum borrowing amount       3,500,000,000        
Commercial paper, amount outstanding       0     0  
Credit Facility | Line of Credit                
Line of Credit Facility                
Line of credit, maximum capacity       $ 3,500,000,000        
Term of debt instrument       5 years        
Line of credit, amount outstanding       $ 0     $ 0  
Senior Notes 2019 | Senior notes | Medtronic Luxco                
Senior Notes                
Number of tranches | tranche               6
Principal value | €               € 5,000,000,000.0
Cash proceeds, net of discounts and issuance costs     $ 5,600,000,000          
Medtronic Inc, CIFSA, and Medtronic Luxco Senior Notes | Senior notes                
Senior Notes                
Extinguishment of debt   $ 4,600,000,000            
Total consideration   $ 5,000,000,000.0            
Loss on extinguishment of debt         $ 413,000,000